"It has been suggested that treatment with levothyroxine may be considered in patients aged 65 years or older with subclinical hypothyroidism (TSH range 7.0-9.9 mIU/L) based on observational data ...

WASHINGTON, D.C. – Two different doses of a thyroid medication are being recalled because they're not potent enough. The Food and Drug Administration announced Thursday that Acella Pharmaceuticals is ...

March 30 (Reuters) - Viridian Therapeutics said on Monday its experimental drug met the main goal in late-stage study, when ...

Add Yahoo as a preferred source to see more of our stories on Google. A popular thyroid medication taken by 23 million Americans may be associated with bone loss, a startling new study finds.

WASHINGTON D.C., DC — After testing and complaints from consumers, the FDA recently announced that two lots of tablets of the drug NP Thyroid was being voluntarily recalled. NP Thyroid was recalled ...

Levothyroxine, a drug used to treat hypothyroidism, can lead to reduced bone mass and density in older adults with normal thyroid levels, a small cohort study has shown. Researchers from Johns Hopkins ...

The findings could help Amgen defend Tepezza’s market-leading position against emerging rivals, though some analysts expressed doubt about its competitive standing.

There is a growing list of medications known to adversely affect thyroid function or interpretation of the results of standard thyroid laboratory testing. Many of these drugs are commonly used ...

By Siddhi Mahatole March 30 (Reuters) - Viridian Therapeutics said on Monday its experimental drug met the main goal in a late-stage study, when tested in patients with active thyroid eye disease.